Delivery Order SPE2DB24D1205-SPE2DB24FCTXH
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$43K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Humira (Adalimumab) auto-injector pens. The contract is a delivery order with a firm-fixed price of $49,000.29 and a performance period ending on September 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract, worth $16,460.11, is for the delivery of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract has an ultimate completion date of October 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as the parent company. This contract is a delivery order under a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) injection pens. The contract is a $6,538.28 firm-fixed-price delivery order with a completion date of September 6, 2024. The contract is not a set-aside award. AmerisourceBergen, through its Corporate Office division, will provide the Humira medication to support military treatment facilities and other government...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (adalimumab) autoinjector pens. The contract, valued at $1,761.66, is a delivery order on an existing Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp). This IDC, worth up to $999,999,999.00, serves as the primary vehicle for Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (Adalimumab) pens to the government. The award, valued at $8,273.50, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) prefilled pens. The award has a ceiling value of $24,079.84 and an ultimate completion date of September 17, 2024. The contract is a delivery order with a firm fixed-price pricing type, and there is no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Humira (adalimumab) auto-injector pens. The contract has a firm fixed price of $5,578.41 and a completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this contract to provide the Humira drug product to the DLA, which supports the healthcare needs of military personnel, veterans, and other federal...
This federal contract award, SPE2DB22D3016|SPE2DB24FBFS1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (adalimumab) 80 mg/0.8 mL pens. The $21,033.74 firm-fixed-price delivery order contract has an ultimate completion date of September 3, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this contract to supply the Humira medication to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Humira (adalimumab) 40 mg/0.4 mL autoinjector pens. The $5,488.68 firm fixed-price contract has an ultimate completion date of August 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts to provide a wide range of prescription medications, medical supplies, and equipment to various government agencies and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Humira (adalimumab) auto-injector pens. The contract, valued at $4,612.28, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of...